AAAAAA

   
Results: 1-12 |
Results: 12
Expression and activation of a C-terminal truncated isoform of STAT5 (STAT5 Delta) following interleukin 2 administration or AZT monotherapy in HIV-infected individuals
Authors: Bovolenta, C Camorali, L Mauri, M Ghezzi, S Nozza, S Tambussi, G Lazzarin, A Poli, G
Citation: C. Bovolenta et al., Expression and activation of a C-terminal truncated isoform of STAT5 (STAT5 Delta) following interleukin 2 administration or AZT monotherapy in HIV-infected individuals, CLIN IMMUNO, 99(1), 2001, pp. 75-81
New directions in economic anthropology.
Authors: Ghezzi, S
Citation: S. Ghezzi, New directions in economic anthropology., INT J URBAN, 25(2), 2001, pp. 462-464
Spreading of HIV-specific CD8(+) T-cell repertoire in long-term nonprogressors and its role in the control of viral load and disease activity
Authors: Propato, A Schiaffella, E Vicenzi, E Francavilla, V Baloni, L Paroli, M Finocchi, L Tanigaki, N Ghezzi, S Ferrara, R Chesnut, R Livingston, B Sette, A Paganelli, R Aiuti, F Poli, G Barnaba, V
Citation: A. Propato et al., Spreading of HIV-specific CD8(+) T-cell repertoire in long-term nonprogressors and its role in the control of viral load and disease activity, HUMAN IMMUN, 62(6), 2001, pp. 561-576
Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands
Authors: Ghezzi, S Menzo, S Brambilla, A Bordignon, PP Lorini, AL Clementi, M Poli, G Vicenzi, E
Citation: S. Ghezzi et al., Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands, VIROLOGY, 280(2), 2001, pp. 253-261
Efficacy of low-dose intermittent subcutaneous interleukin (IL)-2 in antiviral drug-experienced human immunodeficiency virus-infected persons with detectable virus load: A controlled study of 3 IL-2 regimens with antiviral drug therapy
Authors: Tambussi, G Ghezzi, S Nozza, S Vallanti, G Magenta, L Guffanti, M Brambilla, A Vicenzi, E Carrera, P Racca, S Soldini, L Gianotti, N Murone, M Veglia, F Poli, G Lazzarin, A
Citation: G. Tambussi et al., Efficacy of low-dose intermittent subcutaneous interleukin (IL)-2 in antiviral drug-experienced human immunodeficiency virus-infected persons with detectable virus load: A controlled study of 3 IL-2 regimens with antiviral drug therapy, J INFEC DIS, 183(10), 2001, pp. 1476-1484
Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1 alpha, and MCP-3, and enhancement by MCP-1
Authors: Vicenzi, E Alfano, M Ghezzi, S Gatti, A Veglia, F Lazzarin, A Sozzani, S Mantovani, A Poli, G
Citation: E. Vicenzi et al., Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1 alpha, and MCP-3, and enhancement by MCP-1, J LEUK BIOL, 68(3), 2000, pp. 405-412
CCR2-641 polymorphism, syncytium-inducing human immunodeficiency virus strains, and disease progression
Authors: Vicenzi, E Ghezzi, S Brambilla, A Sheppard, HW Lazzarin, A Poli, G Michael, NL
Citation: E. Vicenzi et al., CCR2-641 polymorphism, syncytium-inducing human immunodeficiency virus strains, and disease progression, J INFEC DIS, 182(5), 2000, pp. 1579-1580
Shorter survival of SDF1-3 ' Al3 ' A homozygotes linked to CD4(+) T cell decrease in advanced human immunodeficiency virus type I infection
Authors: Brambilla, A Villa, C Rizzardi, G Veglia, F Ghezzi, S Lazzarin, A Cusini, M Muratori, S Santagostino, E Gringeri, A Louie, LG Sheppard, HW Poli, G Michael, NL Pantaleo, G Vicenzi, E
Citation: A. Brambilla et al., Shorter survival of SDF1-3 ' Al3 ' A homozygotes linked to CD4(+) T cell decrease in advanced human immunodeficiency virus type I infection, J INFEC DIS, 182(1), 2000, pp. 311-315
Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat
Authors: Ghezzi, S Noonan, DM Aluigi, MG Vallanti, G Cota, M Benelli, R Morini, M Reeves, JD Vicenzi, E Poli, G Albini, A
Citation: S. Ghezzi et al., Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat, BIOC BIOP R, 270(3), 2000, pp. 992-996
In vivo administration of recombinant IL-2 to individuals infected by HIV down-modulates the binding and expression of the transcription factors ying-yang-1 and leader binding protein-1/late simian virus 40 factor
Authors: Bovolenta, C Camorali, L Lorini, AL Vallanti, G Ghezzi, S Tambussi, G Lazzarin, A Poli, G
Citation: C. Bovolenta et al., In vivo administration of recombinant IL-2 to individuals infected by HIV down-modulates the binding and expression of the transcription factors ying-yang-1 and leader binding protein-1/late simian virus 40 factor, J IMMUNOL, 163(12), 1999, pp. 6892-6897
Constitutive activation of STATs upon in vivo human immunodeficiency virusinfection
Authors: Bovolenta, C Camorali, L Lorini, AL Ghezzi, S Vicenzi, E Lazzarin, A Poli, G
Citation: C. Bovolenta et al., Constitutive activation of STATs upon in vivo human immunodeficiency virusinfection, BLOOD, 94(12), 1999, pp. 4202-4209
Human immunodeficiency virus replication induces monocyte chemotactic protein-1 in human macrophages and U937 promonocytic cells
Authors: Mengozzi, M De Filippi, C Transidico, P Biswas, P Cota, M Ghezzi, S Vicenzi, E Mantovani, A Sozzani, S Poli, G
Citation: M. Mengozzi et al., Human immunodeficiency virus replication induces monocyte chemotactic protein-1 in human macrophages and U937 promonocytic cells, BLOOD, 93(6), 1999, pp. 1851-1857
Risultati: 1-12 |